Novo Nordisk CEO Lars Fruergaard Jorgensen testified before the Senate Health, Education, Labor and Pensions Committee hearing in ...

During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions ...

In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications ...

Patients taking Ozempic were about 60% less likely to have an opioid overdose compared to those taking other diabetes drugs.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

The health benefits of blockbuster weight loss drugs are bridging the stark political divide in the United States.

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Sanders found unlikely common ground with pro-Trump Elon Musk, citing the tech mogul as “right” on “solving obesity” in a ...

The preliminary findings from this study point to the possibility that GLP-1 medications may have value in helping to prevent ...

In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the me ...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...